Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma

CONCLUSIONS: The detection of K17 in 10% or greater of PDAC cells identified patients with shortest survival. Among patients with low K17 PDACs, 5-FU-based treatment was more likely than gemcitabine-based therapies to extend survival.PMID:38642081 | DOI:10.1093/ajcp/aqae038

Source: American Journal of Clinical Pathology - April 20, 2024 Category: Pathology Authors: Lyanne A Delgado-Coka Lucia Roa-Pe ña Sruthi Babu Michael Horowitz Emanuel F Petricoin Lynn M Matrisian Edik M Blais Natalia Marchenko Felicia D Allard Ali Akalin Wei Jiang Brent K Larson Andrew E Hendifar Vincent J Picozzi Minsig Choi Kenneth R Shroyer Source Type: research